ID

12930

Description

Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine; ODM derived from: https://clinicaltrials.gov/show/NCT00124072

Link

https://clinicaltrials.gov/show/NCT00124072

Keywords

  1. 1/6/16 1/6/16 -
Copyright Holder

CC BY-NC 3.0

Uploaded on

January 6, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Cardiovascular Disease NCT00124072

Eligibility Cardiovascular Disease NCT00124072

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
prior myocardial infarction
Description

prior myocardial infarction

Data type

boolean

Alias
UMLS CUI [1]
C0027051
statin therapy indicated
Description

statin therapy

Data type

boolean

Alias
UMLS CUI [1]
C0360714
no clear indication for folic acid
Description

folic acid

Data type

boolean

Alias
UMLS CUI [1]
C0016410
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
no clear contraindication to study treatments
Description

no clear contraindication to study treatments

Data type

boolean

Alias
UMLS CUI [1]
C0087111
screening plasma total cholesterol <3.5 mmol/l in patient already on statin therapy, or <4.5 mmol/l in patient not on statin therapy
Description

cholesterol

Data type

boolean

Alias
UMLS CUI [1]
C1445957
chronic liver disease
Description

chronic liver disease

Data type

boolean

Alias
UMLS CUI [1]
C0341439
severe renal disease or evidence of renal impairment
Description

renal disease

Data type

boolean

Alias
UMLS CUI [1]
C0022658
inflammatory muscle disease
Description

inflammatory muscle disease

Data type

boolean

Alias
UMLS CUI [1]
C0026848
concurrent treatment with fibrates or high-dose niacin
Description

fibrates or high-dose niacin

Data type

boolean

Alias
UMLS CUI [1]
C1449704
UMLS CUI [2]
C0027996
concurrent treatment with cyclosporin (or condition likely to result in organ transplantation and the need for cyclosporin), nefazodone, methotrexate, systemic azole antifungal or systemic macrolide antibiotics
Description

concurrent treatment with cyclosporin (or condition likely to result in organ transplantation and the need for cyclosporin), nefazodone, methotrexate, systemic azole antifungal or systemic macrolide antibiotics

Data type

boolean

Alias
UMLS CUI [1]
C0010592
UMLS CUI [2]
C0068485
UMLS CUI [3]
C0025677
UMLS CUI [4]
C0004504
UMLS CUI [5]
C0003240
child bearing potential
Description

child bearing potential

Data type

boolean

Alias
UMLS CUI [1]
C0015895
no other predominant medical problem (other than coronary heart disease [chd]) which might limit compliance with 5 years of study treatment
Description

no other predominant medical problem (other than coronary heart disease [chd]) which might limit compliance with 5 years of study treatment

Data type

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488

Similar models

Eligibility Cardiovascular Disease NCT00124072

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
prior myocardial infarction
Item
prior myocardial infarction
boolean
C0027051 (UMLS CUI [1])
statin therapy
Item
statin therapy indicated
boolean
C0360714 (UMLS CUI [1])
folic acid
Item
no clear indication for folic acid
boolean
C0016410 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
no clear contraindication to study treatments
Item
no clear contraindication to study treatments
boolean
C0087111 (UMLS CUI [1])
cholesterol
Item
screening plasma total cholesterol <3.5 mmol/l in patient already on statin therapy, or <4.5 mmol/l in patient not on statin therapy
boolean
C1445957 (UMLS CUI [1])
chronic liver disease
Item
chronic liver disease
boolean
C0341439 (UMLS CUI [1])
renal disease
Item
severe renal disease or evidence of renal impairment
boolean
C0022658 (UMLS CUI [1])
inflammatory muscle disease
Item
inflammatory muscle disease
boolean
C0026848 (UMLS CUI [1])
fibrates or high-dose niacin
Item
concurrent treatment with fibrates or high-dose niacin
boolean
C1449704 (UMLS CUI [1])
C0027996 (UMLS CUI [2])
concurrent treatment with cyclosporin (or condition likely to result in organ transplantation and the need for cyclosporin), nefazodone, methotrexate, systemic azole antifungal or systemic macrolide antibiotics
Item
concurrent treatment with cyclosporin (or condition likely to result in organ transplantation and the need for cyclosporin), nefazodone, methotrexate, systemic azole antifungal or systemic macrolide antibiotics
boolean
C0010592 (UMLS CUI [1])
C0068485 (UMLS CUI [2])
C0025677 (UMLS CUI [3])
C0004504 (UMLS CUI [4])
C0003240 (UMLS CUI [5])
child bearing potential
Item
child bearing potential
boolean
C0015895 (UMLS CUI [1])
no other predominant medical problem (other than coronary heart disease [chd]) which might limit compliance with 5 years of study treatment
Item
no other predominant medical problem (other than coronary heart disease [chd]) which might limit compliance with 5 years of study treatment
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial